Relapse of coccidioidomycosis despite immune reconstitution after fluconazole secondary prophylaxis in a patient with AIDS

Mycoses

Volumn 46, Issue 1-2, 2003, Pages 42-44

  Mathew, G ^a,b   Smedema, M ^c   Wheat, L J ^a,b,c   Goldman, Mitchell ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Histoplasmosis Reference Laboratory   (United States)

Author keywords

AIDS; Coccidioidomycosis; Immune reconstitution

Indexed keywords

FLUCONAZOLE; PYRROLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; CLINICAL TRIAL; COCCIDIOIDOMYCOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; SAFETY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; DRUG THERAPY, COMBINATION; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RECURRENCE; WITHHOLDING TREATMENT;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0242501533     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2003.00833.x     Document Type: Article

References (11)

1. Campbell CC. Histoplasmosis and other respiratory mycoses in the tropics. Indust Trop Health 1967; 6: 145.
2. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988; 2: 199.
3. Ampel NM. Coccidioidomycosis in the HIV-infected patient: diagnosis and treatment. AIDS Reader 1992; January/February: 12.
4. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993; 94: 235.
5. Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL. Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis 2000; 30: 658.
6. De Quiros JCLB, Miro JM, Pena JM et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. N Engl J Med 2001; 344: 159.
7. Aberg JA, Yajko DM, Jacobson MA. Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. J Infect Dis 1998; 178: 1446.
8. Martínez E, García-Viejo MA, Marcos MA et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy. AIDS 2000; 14: 2615.
9. Mussini C, Cossarizza A, Pezzotti P et al. Discontinuation or continuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with HAART. Eighth Conference on Retroviruses and Opportunistic Infections. 1: 207.
10. Waitz JA, Bartlett MS, Ghannoum MA et al. Reference Method of Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard. 97. M27-A (ISBN 1-56238-328-0). 1-29. Wayne. PA: National Committee on Clinical Laboratory Standards.
11. Fish DG, Ampel NM, Galgiani JNet al. Coccidioidomycosis during human immunodeficiency virus infection: a review of 77 patients. Medicine 1990; 69: 384.